Metropolitan Life Insurance Company (MetLife)’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,926
Closed -$140K 2220
2024
Q1
$140K Sell
2,926
-178
-6% -$9.51K 0.01% 874
2023
Q4
$202K Hold
3,104
0.01% 725
2023
Q3
$203K Buy
3,104
+273
+10% +$17.2K 0.01% 669
2023
Q2
$165K Buy
2,831
+247
+10% +$15.6K 0.01% 762
2023
Q1
$160K Sell
2,584
-397
-13% -$23.8K 0.01% 759
2022
Q4
$189K Buy
2,981
+70
+2% +$5.08K 0.01% 738
2022
Q3
$211K Hold
2,911
0.01% 656
2022
Q2
$198K Buy
2,911
+699
+32% +$50.2K 0.01% 698
2022
Q1
$200K Sell
2,212
-6,604
-75% -$541K 0.01% 817
2021
Q4
$805K Sell
8,816
-543
-6% -$46.5K 0.01% 1126
2021
Q3
$759K Buy
9,359
+5
+0.1% +$420 0.01% 1160
2021
Q2
$873K Buy
9,354
+4,729
+102% +$458K 0.01% 1120
2021
Q1
$495K Buy
4,625
+2,286
+98% +$237K 0.01% 1417
2020
Q4
$204K Hold
2,339
﹤0.01% 1921
2020
Q3
$161K Buy
+2,339
New +$150K ﹤0.01% 1918

Other funds holding NARI

Metropolitan Life Insurance Company (MetLife)'s NARI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 2,926 shares — an estimated $140K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NARI in Q3 2020 and held it in 15 quarters. The position peaked at $873K in Q2 2021. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,926 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $140K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Inari Medical, Inc. Common Stock position peaked at $873K in Q2 2021.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.